Stocks Health care TKNO
NASDAQ · Health careAlpha Teknova, Inc. (TKNO)
Alpha Teknova, Inc. brought in $46M of revenue over the twelve months to September 30, 2026, up 15.4% from a year earlier. It posted a net loss of $16M. In fiscal 2025 capital spending exceeded operating cash flow by $9.8M. At September 30, 2026 it held $6.6M in cash against $13.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Alpha Teknova, Inc.
- Net worth
- Alpha Teknova, Inc. has a market value (market cap) of $471.4M at the latest share price, and shareholders' equity of $59.8M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $40.5M (+7.4% year on year), with a net loss of $17.3M. Over the 12 months to September 30, 2026: revenue $46M, net loss $16M.
- Cash flow
- In fiscal 2025 operations used $8.6M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Alpha Teknova, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Alpha Teknova, Inc. does
Alpha Teknova, Inc. is registered with the SEC under industry code SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Its shares trade on NASDAQ under the ticker TKNO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $40.5M | -$17.3M | -$0.32 | -$9.8M |
| 2024 | $37.7M | -$26.7M | -$0.57 | -$13.5M |
| 2023 | $36.7M | -$36.8M | -$1.16 | -$26.7M |
| 2022 | $41.4M | -$47.5M | -$1.69 | -$55.5M |
| 2021 | $36.9M | -$9.8M | -$0.61 | -$28.9M |
| 2021 | $31.3M | $3.6M | $0.16 | -$3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where TKNO ranks in Health care
Latest SEC filings
What Alpha Teknova, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 22% to $12.7M versus the same quarter last year; diluted EPS -$0.06 versus -$0.08.
- November 4, 2026
- October 21, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 18% to $12.2M versus the same quarter last year; diluted EPS -$0.06 versus -$0.07.
- August 5, 2026
- June 1, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 13% to $11.1M versus the same quarter last year; diluted EPS -$0.08 versus -$0.09.
- May 6, 2026
- April 21, 2026
- April 21, 2026Additional proxy material DEFA14A
Insider trades
What the people running Alpha Teknova, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 14, 2026 | Demski Martha JDirector | Other change | 12,000 | - |
| July 14, 2026 | Demski Martha JDirector | Other changeindirect | 12,000 | - |
| March 6, 2026 | Lowell MatthewChief Financial Officer | Bought | 40,000 | $87.6K |
| March 6, 2026 | Gunstream StephenPresident and CEO, Director | Bought | 26,000 | $55.8K |
Who owns TKNO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
3 insiders reported holding 449,873 shares in total, about $3.9M at the last price.
| Holder | Shares |
|---|---|
| Gunstream StephenPresident and CEO, Director | 269,497 |
| Lowell MatthewChief Financial Officer | 168,376 |
| Demski Martha JDirector | 12,00012,000 held indirectly |
Questions about TKNO
What does Alpha Teknova, Inc. do?
Alpha Teknova, Inc. is a company in the Health care sector, listed on NASDAQ as TKNO. Its shares trade on NASDAQ under the ticker TKNO.
What is Alpha Teknova, Inc.'s net worth?
Alpha Teknova, Inc. has a market value (market cap) of $471.4M at the latest share price, and shareholders' equity of $59.8M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Alpha Teknova, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $16M on revenue of $46M.
How much revenue does Alpha Teknova, Inc. make?
Over the twelve months to September 30, 2026 Alpha Teknova, Inc. reported revenue of $46M. That is 15.4% more than a year earlier.
When did Alpha Teknova, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Alpha Teknova, Inc.'s next earnings report?
Alpha Teknova, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare TKNO with
Follow TKNO
Get an email when Alpha Teknova, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Alpha Teknova, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.